Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Nihonbashi Life Science Building - Hall 201

May 30, 2017 9:20 AM - May 30, 2017 5:45 PM

2-3-11 Nihonbashi-honcho, Chuo-ku, Tokyo, 103-0023 Japan

4th DIA Risk Management Workshop in Japan

Overview

This workshop will be conducted in Japanese Language only.

Click Here to View the Program in Japanese

Program Committee

  • Rei  Maeda
    Rei Maeda Consultant
    Independent Consultant for Drug PV, Japan
  • Fumiyo  Aoki
    Fumiyo Aoki Team Manager, Pharmacovigilance
    AbbVie GK, Japan
  • Hiroya  Asou, MD, PhD, MBA
    Hiroya Asou, MD, PhD, MBA Senior Medical Advisor, Global Patient Safety Japan
    Eli Lilly Japan K.K., Japan
  • Kasumi  Daidoji, PhD, RPh
    Kasumi Daidoji, PhD, RPh Associate Director, Clinical Planning & Development Dept., Medical Headquarters
    Eisai Co., Ltd., Japan
  • Kazuhiko  Ishida, MSc, RPh
    Kazuhiko Ishida, MSc, RPh Director, Pharmacovigilance
    Astellas Pharma Inc., Japan
  • Rie  Matsui, RPh
    Rie Matsui, RPh Senior Director, Regional Labeling Head for APAC, International Labeling
    Pfizer R&D Japan G.K., Japan
  • Kou  Miyakawa
    Kou Miyakawa Director
    Takeda Pharmaceutical Company Limited, Japan
  • Hiroyuki  Murakami
    Hiroyuki Murakami Duputy Review Director, Office of New Drug I
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Mitsuo  Saito, PhD
    Mitsuo Saito, PhD Technical Advisor
    Institute For Health Vigilance, Japan
  • Junko  Sato, PhD
    Junko Sato, PhD Associate Executive Director
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Tomoko  Yamada
    Tomoko Yamada Associate director, Safety risk management, Pharmacovigilance
    MSD K.K., Japan

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.